CHINA NATIONAL MEDICINES CORPORATION LTD.

Consensus China National Medicines Corporation Ltd.

Equities

600511

CNE000001D56

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
36.34 ^CNY	+0.25%		+4.58%	+26.97%

Apr. 25	China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	MT

Evolution of the average Target Price on China National Medicines Corporation Ltd.

Price target over the last 5 years

History of analyst recommendation changes

844fc93e1a950ef0680567b6dc94.m3VwPL1pLsY7tfivPxlxCfHNhrDLPJgaiyyvilqX5ZU.7DIff_grGJlk6sGfXngWVqKB1IjmdfJ0-mrL8B39tNKoGztkyTFtj3PHmw~61643c3e7ba6c4cc875b79a657bc2cdd

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

36.34 CNY

Average target price

44.3 CNY

Spread / Average Target

+21.90%

High Price Target

47.6 CNY

Spread / Highest target

+30.99%

Low Price Target

41 CNY

Spread / Lowest Target

+12.82%

Consensus detail

Consensus revision (last 18 months)

Ratings for China National Medicines Corporation Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar